Persistent Asset Partners LTD Eledon Pharmaceuticals, Inc. Call Options Transaction History
Persistent Asset Partners LTD
- $145 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELDN
# of Institutions
87Shares Held
37MCall Options Held
48.5KPut Options Held
30.3K-
Bvf Inc San Francisco, CA6.29MShares$13.4 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$7.6 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$6.96 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$5.54 Million1.08% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$4.41 Million0.21% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $29.3M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...